NYSE:GEN - Genesis HealthCare Stock Price, Price Target & More

$1.57 -0.03 (-1.88 %)
(As of 04/20/2018 12:25 PM ET)
Previous Close$1.60
Today's Range$1.56 - $1.66
52-Week Range$0.60 - $2.68
Volume197,446 shs
Average Volume685,406 shs
Market Capitalization$242.43 million
P/E Ratio-0.75
Dividend YieldN/A
Beta0.91

About Genesis HealthCare (NYSE:GEN)

Genesis HealthCare logoGenesis Healthcare, Inc. is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services. As of December 31, 2016, the Company offered inpatient services through its network of 499 skilled nursing and assisted/senior living facilities across 34 states, consisting of 473 skilled nursing facilities and 26 stand-alone assisted/senior living facilities. Its services focus primarily on the medical and physical issues facing elderly patients and are provided by its skilled nursing companies, assisted or senior living communities, integrated and third-party rehabilitation therapy business, and other ancillary services.

Receive GEN News and Ratings via Email

Sign-up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Skilled nursing care facilities
Sub-IndustryN/A
SectorMedical
SymbolNYSE:GEN
CUSIPN/A
Phone610-444-6350

Debt

Debt-to-Equity Ratio-2.98%
Current Ratio1.05%
Quick Ratio1.05%

Price-To-Earnings

Trailing P/E Ratio-0.75
Forward P/E Ratio-1.21
P/E GrowthN/A

Sales & Book Value

Annual Sales$5.37 billion
Price / Sales0.05
Cash Flow$2.7069 per share
Price / Cash0.58
Book Value($10.74) per share
Price / Book-0.15

Profitability

EPS (Most Recent Fiscal Year)($2.11)
Net Income$-578,980,000.00
Net Margins-10.77%
Return on EquityN/A
Return on Assets-2.76%

Miscellaneous

Employees68,700
Outstanding Shares156,400,000

How to Become a New Pot Stock Millionaire

Genesis HealthCare (NYSE:GEN) Frequently Asked Questions

What is Genesis HealthCare's stock symbol?

Genesis HealthCare trades on the New York Stock Exchange (NYSE) under the ticker symbol "GEN."

How were Genesis HealthCare's earnings last quarter?

Genesis HealthCare (NYSE:GEN) released its earnings results on Friday, March, 16th. The company reported ($0.36) earnings per share for the quarter, missing analysts' consensus estimates of ($0.31) by $0.05. The business had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.34 billion. View Genesis HealthCare's Earnings History.

What price target have analysts set for GEN?

3 analysts have issued 12 month target prices for Genesis HealthCare's shares. Their forecasts range from $2.00 to $2.00. On average, they expect Genesis HealthCare's stock price to reach $2.00 in the next twelve months. View Analyst Ratings for Genesis HealthCare.

Who are some of Genesis HealthCare's key competitors?

Who are Genesis HealthCare's key executives?

Genesis HealthCare's management team includes the folowing people:
  • Robert H. Fish, Chairman of the Board
  • George V. Hager Jr., Chief Executive Officer, Director
  • Thomas DiVittorio, Chief Financial Officer
  • Paul David Bach, Chief Operating Officer
  • Jeanne Phillips, Chief Human Resource Officer, Senior Vice President
  • , Bio & Compensation - 
  • David C. Almquist, Executive Vice President, President - West and East Divisions
  • Richard P. Blinn, Executive Vice President, President - Northeast Division and Southeast Divisions
  • JoAnne Reifsnyder Ph.D., Executive Vice President - Clinical Operations, Chief Nursing Officer
  • Richard L. Castor, Senior Vice President, Chief Information Officer
  • Michael S. Sherman, Senior Vice President, General Counsel, Assistant Treasurer, Secretary

Has Genesis HealthCare been receiving favorable news coverage?

News articles about GEN stock have trended somewhat positive this week, according to Accern Sentiment Analysis. Accern ranks the sentiment of news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Genesis HealthCare earned a daily sentiment score of 0.04 on Accern's scale. They also gave headlines about the company an impact score of 46.33 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

Who are Genesis HealthCare's major shareholders?

Genesis HealthCare's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include FISHMAN STEVEN E. (57.10%). Company insiders that own Genesis HealthCare stock include Daniel Allen Hirschfeld, George V Hager Jr, Joanne Susan Reifsnyder, Michael Scott Sherman, Paul David Bach, Stephen Scott Young and Thomas Divittorio. View Institutional Ownership Trends for Genesis HealthCare.

How do I buy shares of Genesis HealthCare?

Shares of GEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Genesis HealthCare's stock price today?

One share of GEN stock can currently be purchased for approximately $1.57.

How big of a company is Genesis HealthCare?

Genesis HealthCare has a market capitalization of $242.43 million and generates $5.37 billion in revenue each year. The company earns $-578,980,000.00 in net income (profit) each year or ($2.11) on an earnings per share basis. Genesis HealthCare employs 68,700 workers across the globe.

How can I contact Genesis HealthCare?

Genesis HealthCare's mailing address is 101 EAST STATE STREET, KENNETT SQUARE PA, 19348. The company can be reached via phone at 610-444-6350 or via email at [email protected]


MarketBeat Community Rating for Genesis HealthCare (GEN)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  150 (Vote Outperform)
Underperform Votes:  217 (Vote Underperform)
Total Votes:  367
MarketBeat's community ratings are surveys of what our community members think about Genesis HealthCare and other stocks. Vote "Outperform" if you believe GEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GEN will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Genesis HealthCare (NYSE:GEN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Genesis HealthCare in the last 12 months. Their average twelve-month price target is $2.00, suggesting that the stock has a possible upside of 27.39%. The high price target for GEN is $2.00 and the low price target for GEN is $2.00. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldBuyBuy
Consensus Rating Score: 2.332.332.502.50
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $2.00$2.00$2.00$2.00
Price Target Upside: 27.39% upside30.72% upside96.08% upside96.08% upside

Genesis HealthCare (NYSE:GEN) Consensus Price Target History

Price Target History for Genesis HealthCare (NYSE:GEN)

Genesis HealthCare (NYSE:GEN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/19/2018StephensReiterated RatingHold$2.00HighView Rating Details
9/13/2017Royal Bank of CanadaReiterated RatingHold$2.00LowView Rating Details
7/5/2017Cantor FitzgeraldInitiated CoverageOverweightHighView Rating Details
9/19/2016Bank of AmericaSet Price TargetSell$1.80N/AView Rating Details
8/22/2016UBSReiterated RatingSellN/AView Rating Details
(Data available from 4/20/2016 forward)

Earnings

Genesis HealthCare (NYSE:GEN) Earnings History and Estimates Chart

Earnings by Quarter for Genesis HealthCare (NYSE:GEN)

Genesis HealthCare (NYSE:GEN) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.3 EPS
Next Year EPS Consensus Estimate: $-1.19 EPS

Genesis HealthCare (NYSE GEN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/16/2018Q4 2017($0.31)($0.36)$1.34 billion$1.3279 billionViewN/AView Earnings Details
11/8/2017Q3 2017($0.30)($0.36)$1.3430 billion$1.3155 billionViewN/AView Earnings Details
8/8/2017Q2 2017($0.26)($0.32)$1.3660 billion$1.3413 billionViewN/AView Earnings Details
5/9/2017Q1 17($0.25)($0.50)$1.4010 billion$1.3891 billionViewListenView Earnings Details
3/6/2017Q4 2016($0.64)$1.4029 billionViewN/AView Earnings Details
11/3/2016Q3($0.40)($0.23)$1.39 billion$1.4190 billionViewN/AView Earnings Details
8/4/2016Q2$0.01($0.26)$1.40 billion$1.44 billionViewN/AView Earnings Details
5/9/2016Q1$0.03($0.01)$1.43 billion$1.47 billionViewN/AView Earnings Details
2/22/2016Q4 2015($0.05)($0.05)$1.4407 billionViewN/AView Earnings Details
11/5/2015Q315$0.07$0.07$1.42 billion$1.42 billionViewN/AView Earnings Details
8/6/2015Q215$0.09$0.14$1.43 billion$1.41 billionViewN/AView Earnings Details
5/7/2015Q1 2015$0.04$0.07$1.4291 billion$1.3430 billionViewN/AView Earnings Details
2/19/2015Q412$0.14$0.14$209.50 million$1.19 billionViewN/AView Earnings Details
11/3/2014Q314$0.07$0.13$208.10 million$208.60 millionViewListenView Earnings Details
8/11/2014Q214$0.06$0.07$209.15 million$207.00 millionViewListenView Earnings Details
5/5/2014Q114$0.07$0.06$210.39 million$207.30 millionViewListenView Earnings Details
2/11/2014Q413$0.10$0.06$215.35 million$208.30 millionViewListenView Earnings Details
11/4/2013Q313$0.10$0.06$214.47 million$212.40 millionViewN/AView Earnings Details
8/5/2013Q2 2013$0.16$0.09$219.58 million$213.70 millionViewN/AView Earnings Details
5/6/2013Q1 2013$0.18$0.10$222.52 million$218.90 millionViewN/AView Earnings Details
2/11/2013Q4 2012$0.19$0.16$219.67 million$219.20 millionViewN/AView Earnings Details
11/9/2012Q312$0.03$0.18$935.06 millionViewN/AView Earnings Details
11/5/2012Q312$0.20$0.21$218.92 million$216.60 millionViewN/AView Earnings Details
8/8/2012$0.19$0.18ViewN/AView Earnings Details
5/2/2012$0.19$0.17ViewN/AView Earnings Details
2/13/2012$0.15$0.19ViewN/AView Earnings Details
10/31/2011$0.30$0.32ViewN/AView Earnings Details
8/1/2011$0.31$0.30ViewN/AView Earnings Details
5/3/2011$0.30$0.34ViewN/AView Earnings Details
2/14/2011$0.28$0.31ViewN/AView Earnings Details
11/1/2010Q3 2010$0.20$0.25ViewN/AView Earnings Details
8/5/2010Q2 2010$0.21$0.24ViewN/AView Earnings Details
5/3/2010Q1 2010$0.23$0.24ViewN/AView Earnings Details
2/8/2010Q4 2009$0.23$0.25ViewN/AView Earnings Details
11/3/2009Q3 2009$0.22$0.25ViewN/AView Earnings Details
8/4/2009Q2 2009$0.25$0.25ViewN/AView Earnings Details
5/5/2009Q1 2009$0.27$0.29ViewN/AView Earnings Details
2/10/2009Q4 2008$0.27$0.28ViewN/AView Earnings Details
11/6/2008Q3 2008$0.25$0.26ViewN/AView Earnings Details
8/5/2008Q2 2008$0.24$0.24ViewN/AView Earnings Details
5/6/2008Q1 2008$0.23$0.23ViewN/AView Earnings Details
2/12/2008Q4 2007$0.23$0.21ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Genesis HealthCare (NYSE:GEN) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Genesis HealthCare (NYSE GEN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 57.59%
Institutional Ownership Percentage: 18.93%
Insider Trading History for Genesis HealthCare (NYSE:GEN)
Institutional Ownership by Quarter for Genesis HealthCare (NYSE:GEN)

Genesis HealthCare (NYSE GEN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/14/2017Joanne Susan ReifsnyderEVPSell5,269$1.73$9,115.37View SEC Filing  
6/14/2017Michael Scott ShermanSVPSell3,903$1.73$6,752.19View SEC Filing  
6/14/2017Paul David BachCOOSell6,100$1.73$10,553.00View SEC Filing  
6/14/2017Stephen Scott YoungVPSell3,799$1.73$6,572.27View SEC Filing  
6/14/2017Thomas DivittorioCFOSell6,341$1.73$10,969.93View SEC Filing  
6/7/2017Daniel Allen HirschfeldCOOSell2,895$1.61$4,660.95View SEC Filing  
6/7/2017Joanne Susan ReifsnyderEVPSell2,383$1.61$3,836.63View SEC Filing  
6/7/2017Michael Scott ShermanSVPSell1,824$1.61$2,936.64View SEC Filing  
6/7/2017Stephen Scott YoungVPSell1,541$1.61$2,481.01View SEC Filing  
6/7/2017Thomas DivittorioCFOSell2,900$1.61$4,669.00View SEC Filing  
8/29/2016Stephen Scott YoungVPSell10,000$2.38$23,800.00View SEC Filing  
6/8/2016Daniel Allen HirschfeldCOOSell3,009$1.72$5,175.48488,220View SEC Filing  
6/8/2016George V Hager JrCEOSell6,031$1.72$10,373.321,542,780View SEC Filing  
6/8/2016Joanne Susan ReifsnyderEVPSell2,207$1.72$3,796.04286,468View SEC Filing  
6/8/2016Michael Scott ShermanSVPSell1,919$1.72$3,300.68423,220View SEC Filing  
6/8/2016Stephen Scott YoungVPSell1,621$1.72$2,788.12172,495View SEC Filing  
6/8/2016Thomas DivittorioCFOSell3,051$1.72$5,247.72509,220View SEC Filing  
11/12/2015James V MckeonDirectorBuy10,000$4.15$41,500.0029,802View SEC Filing  
11/11/2015Thomas DivittorioCFOBuy20,000$4.34$86,800.00387,220View SEC Filing  
11/14/2013Boyd HendricksonCEOSell48,774$5.02$244,845.48265,430View SEC Filing  
8/6/2013Boyd W HendricksonCEOSell4,983$6.03$30,047.49View SEC Filing  
8/5/2013Boyd W HendricksonCEOSell24,671$6.49$160,114.79View SEC Filing  
8/2/2013Boyd W HendricksonCEOSell45,346$6.58$298,376.68View SEC Filing  
7/2/2013Boyd W HendricksonCEOSell29,988$6.46$193,722.48View SEC Filing  
7/1/2013Boyd W HendricksonCEOSell28,112$6.61$185,820.32View SEC Filing  
11/1/2012Boyd W HendricksonCEOSell1,567$8.00$12,536.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Genesis HealthCare (NYSE GEN) News Headlines

Source:
DateHeadline
-$0.31 EPS Expected for Genesis HealthCare (GEN) This Quarter-$0.31 EPS Expected for Genesis HealthCare (GEN) This Quarter
www.americanbankingnews.com - April 20 at 11:28 AM
Genesis HealthCare (GEN) Cut to Strong Sell at ValuEngineGenesis HealthCare (GEN) Cut to Strong Sell at ValuEngine
www.americanbankingnews.com - April 18 at 4:44 PM
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2018Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2018
finance.yahoo.com - April 17 at 8:47 AM
Genesis selling off 2 dozen skilled nursing facilities in TexasGenesis selling off 2 dozen skilled nursing facilities in Texas
finance.yahoo.com - April 12 at 5:23 PM
Centers Health Care Hires Heidi Hendrix, RN, As New Chief Nursing OfficerCenters Health Care Hires Heidi Hendrix, RN, As New Chief Nursing Officer
www.bizjournals.com - April 12 at 8:59 AM
Genesis Healthcare to divest 23 nursing facilitiesGenesis Healthcare to divest 23 nursing facilities
seekingalpha.com - April 12 at 8:59 AM
Can Genomed Spólka Akcyjna (WSE:GEN) Improve Your Portfolio Returns?Can Genomed Spólka Akcyjna (WSE:GEN) Improve Your Portfolio Returns?
finance.yahoo.com - April 12 at 8:59 AM
Genesis Energy Limited (NZE:GNE): Time For A Financial Health CheckGenesis Energy Limited (NZE:GNE): Time For A Financial Health Check
finance.yahoo.com - April 11 at 8:46 AM
Passing of Genmab A/S’ Annual General MeetingPassing of Genmab A/S’ Annual General Meeting
finance.yahoo.com - April 10 at 5:19 PM
Constitution of the Board of Directors in Genmab A/S and Grant of Restricted Stock Units and Warrants to Employees in GenmabConstitution of the Board of Directors in Genmab A/S and Grant of Restricted Stock Units and Warrants to Employees in Genmab
finance.yahoo.com - April 10 at 5:19 PM
Should You Expect Genomed Spólka Akcyjna (WSE:GEN) To Continue Delivering An ROE Of 29.39%?Should You Expect Genomed Spólka Akcyjna (WSE:GEN) To Continue Delivering An ROE Of 29.39%?
finance.yahoo.com - April 4 at 4:02 PM
Capital Increase in Genmab as a Result of Employee Warrant ExerciseCapital Increase in Genmab as a Result of Employee Warrant Exercise
finance.yahoo.com - April 3 at 5:22 PM
ValuEngine Downgrades Genesis Healthcare (GEN) to HoldValuEngine Downgrades Genesis Healthcare (GEN) to Hold
www.americanbankingnews.com - April 3 at 2:58 PM
Quorum Health (QHC) Names Terry Allison Rappuhn as New Chair; William M. Gracey ResignsQuorum Health (QHC) Names Terry Allison Rappuhn as New Chair; William M. Gracey Resigns
www.streetinsider.com - March 26 at 8:36 AM
Quorum Health (QHC) Names Terry Allison Rappuhn as New Chair; William M. Gracey Resigns - StreetInsider.comQuorum Health (QHC) Names Terry Allison Rappuhn as New Chair; William M. Gracey Resigns - StreetInsider.com
www.streetinsider.com - March 24 at 9:01 AM
Genesis Healthcare riding nursing-home turbulence [Philly.com]Genesis Healthcare riding nursing-home turbulence [Philly.com]
www.bloomberg.com - March 22 at 5:25 PM
Genesis Rehab Services Achieves “World Class” Net Promoter ScoreGenesis Rehab Services Achieves “World Class” Net Promoter Score
finance.yahoo.com - March 22 at 5:25 PM
Genesis Healthcare (GEN) & Its Competitors Head-To-Head SurveyGenesis Healthcare (GEN) & Its Competitors Head-To-Head Survey
www.americanbankingnews.com - March 22 at 1:38 PM
Genesis Healthcare (GEN) Rating Reiterated by StephensGenesis Healthcare (GEN) Rating Reiterated by Stephens
www.americanbankingnews.com - March 19 at 9:30 PM
Should You Be Tempted To Buy Genomed Spólka Akcyjna (WSE:GEN) Because Of Its PE Ratio?Should You Be Tempted To Buy Genomed Spólka Akcyjna (WSE:GEN) Because Of Its PE Ratio?
finance.yahoo.com - March 19 at 5:08 PM
Genesis Healthcare, Inc. (GEN) PT Raised to $2 at Stephens - StreetInsider.comGenesis Healthcare, Inc. (GEN) PT Raised to $2 at Stephens - StreetInsider.com
www.streetinsider.com - March 19 at 8:36 AM
Canon Medical Systems’ Aquilion ONE / GENESIS Edition Delivers Full Suite of Acute Stroke SolutionsCanon Medical Systems’ Aquilion ONE / GENESIS Edition Delivers Full Suite of Acute Stroke Solutions
www.bizjournals.com - March 18 at 8:31 AM
Edited Transcript of GEN earnings conference call or presentation 16-Mar-18 12:30pm GMTEdited Transcript of GEN earnings conference call or presentation 16-Mar-18 12:30pm GMT
finance.yahoo.com - March 17 at 8:42 AM
Genesis Healthcare (GEN) Presents At Barclays Global Healthcare Conference 2018 - SlideshowGenesis Healthcare (GEN) Presents At Barclays Global Healthcare Conference 2018 - Slideshow
seekingalpha.com - March 16 at 6:16 PM
Genesis Healthcare reports 4Q lossGenesis Healthcare reports 4Q loss
finance.yahoo.com - March 16 at 8:34 AM
Genesis HealthCare Reports Fourth Quarter and Fiscal Year End 2017 ResultsGenesis HealthCare Reports Fourth Quarter and Fiscal Year End 2017 Results
finance.yahoo.com - March 16 at 8:34 AM
An Intrinsic Calculation For Genesis Healthcare Inc (NYSE:GEN) Shows It’s 38% UndervaluedAn Intrinsic Calculation For Genesis Healthcare Inc (NYSE:GEN) Shows It’s 38% Undervalued
finance.yahoo.com - March 13 at 7:07 PM
Genesis Healthcare (GEN) Set to Announce Quarterly Earnings on MondayGenesis Healthcare (GEN) Set to Announce Quarterly Earnings on Monday
www.americanbankingnews.com - March 12 at 2:56 AM
Quotidian Technical Highlights on Selected Long-Term Care Facilities Stocks -- Brookdale Senior Living, Envision ... - PR Newswire (press release)Quotidian Technical Highlights on Selected Long-Term Care Facilities Stocks -- Brookdale Senior Living, Envision ... - PR Newswire (press release)
www.prnewswire.com - March 10 at 8:35 AM
Genesis HealthCare Regains Compliance With NYSE Continued Listing Standard - GlobeNewswire (press release)Genesis HealthCare Regains Compliance With NYSE Continued Listing Standard - GlobeNewswire (press release)
globenewswire.com - March 3 at 6:12 PM
At $1.17, Is Genesis Healthcare Inc (NYSE:GEN) A Buy?At $1.17, Is Genesis Healthcare Inc (NYSE:GEN) A Buy?
finance.yahoo.com - March 2 at 5:54 PM
Genesis HealthCare Regains Compliance With NYSE Continued Listing StandardGenesis HealthCare Regains Compliance With NYSE Continued Listing Standard
finance.yahoo.com - March 1 at 5:40 PM
Understanding Genesis Healthcare’s Financial PerformanceUnderstanding Genesis Healthcare’s Financial Performance
finance.yahoo.com - February 27 at 5:45 PM
Key Risks Facing Genesis Healthcare in 2018Key Risks Facing Genesis Healthcare in 2018
finance.yahoo.com - February 27 at 5:45 PM
Exploring Genesis Healthcare’s Business SegmentsExploring Genesis Healthcare’s Business Segments
finance.yahoo.com - February 27 at 5:45 PM
Genesis Healthcare, Pioneer of Genetic Test Service, Raises 1.65 Billion Yen Newly - PR Newswire (press release)Genesis Healthcare, Pioneer of Genetic Test Service, Raises 1.65 Billion Yen Newly - PR Newswire (press release)
www.prnewswire.com - February 27 at 8:34 AM
[$$] Genesis Healthcare Refinances Debt Load Amid Restructuring[$$] Genesis Healthcare Refinances Debt Load Amid Restructuring
finance.yahoo.com - February 23 at 5:44 PM
Shares in U.S. senior housing chains Genesis, Brookdale slideShares in U.S. senior housing chains Genesis, Brookdale slide
www.reuters.com - February 23 at 8:37 AM
Welltower Reports Fourth Quarter 2017 ResultsWelltower Reports Fourth Quarter 2017 Results
www.bizjournals.com - February 22 at 5:28 PM
Genesis Healthcare gets some debt reliefGenesis Healthcare gets some debt relief
finance.yahoo.com - February 22 at 5:28 PM
Asset Sales Continue Holding Down Welltower Inc's ResultsAsset Sales Continue Holding Down Welltower Inc's Results
finance.yahoo.com - February 22 at 5:28 PM
With A -32.62% Earnings Drop Lately, Did Genesis Healthcare Inc (NYSE:GEN) Underperform Its Industry?With A -32.62% Earnings Drop Lately, Did Genesis Healthcare Inc (NYSE:GEN) Underperform Its Industry?
finance.yahoo.com - February 20 at 5:35 PM
BRIEF-Genesis Healthcare To Extend "Lock-Up" Period Of Shares Until July 31BRIEF-Genesis Healthcare To Extend "Lock-Up" Period Of Shares Until July 31
www.reuters.com - February 16 at 5:10 PM
Genesis Healthcare (GEN) Scheduled to Post Quarterly Earnings on TuesdayGenesis Healthcare (GEN) Scheduled to Post Quarterly Earnings on Tuesday
www.americanbankingnews.com - February 13 at 2:56 AM
Blockchain Technology May Change the World, But What Are the Risks?Blockchain Technology May Change the World, But What Are the Risks?
www.thestreet.com - February 10 at 9:38 AM
Nursing home giant Genesis eyes approval for $26M Dracut facilityNursing home giant Genesis eyes approval for $26M Dracut facility
finance.yahoo.com - February 9 at 9:46 AM
Genesis HealthCare to Present at the 36th Annual J. P. Morgan Healthcare Conference on January 11, 2018Genesis HealthCare to Present at the 36th Annual J. P. Morgan Healthcare Conference on January 11, 2018
finance.yahoo.com - January 3 at 5:01 PM
ETFs with exposure to Genesis Healthcare, Inc. : January 1, 2018ETFs with exposure to Genesis Healthcare, Inc. : January 1, 2018
finance.yahoo.com - January 1 at 4:53 PM
ETFs with exposure to Genesis Healthcare, Inc. : December 19, 2017ETFs with exposure to Genesis Healthcare, Inc. : December 19, 2017
finance.yahoo.com - December 19 at 4:57 PM
Genesis Healthcare, Inc. :GEN-US: Earnings Analysis: Q3, 2017 By the Numbers : December 18, 2017Genesis Healthcare, Inc. :GEN-US: Earnings Analysis: Q3, 2017 By the Numbers : December 18, 2017
finance.yahoo.com - December 18 at 4:55 PM

SEC Filings

Genesis HealthCare (NYSE:GEN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Genesis HealthCare (NYSE:GEN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Genesis HealthCare (NYSE GEN) Stock Chart for Friday, April, 20, 2018

Loading chart…

This page was last updated on 4/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.